The Scottish Medicines Consortium has approved funding for four newly licensed medicines, expanding NHS treatments options in Scotland for ovarian cancer, lung cancer, urea cycle disorders and acute hereditary angioedema.
US regulators have accepted for review a targeted, Gram-positive investigational antibiotic developed by UK biopharma Motif Bio for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
The PharmaTimes Communications Team of the Year competition is the only pharma industry awards that tests the competencies and potential of communications agency teams, benchmarking talent agency side. This year sees the introduction of a new 'Charity Challenge', which in partnership with Beating Bowel Cancer and Bowel Cancer UK, will focus on a real life scenario for the first time.
Director of policy and communications at MSD and executive steering group member Harry Brady looks at how the PharmaTimes Marketer and Communications Team of the Year competitions have evolved to embrace the importance of cross-functional working and the value of great healthcare communications in the marketing mix.